Research Article: Mutated DNMT3A creates a public HLADQ- binding neoantigen on acute myeloid leukemia
Abstract:
Introduction: Patients with acute myeloid leukemia (AML) often carry the same gene mutations. Neoantigens encoded by these mutations are attractive targets for immunotherapy.
No summary available.